Advancements in artificial intelligence (AI) are increasingly intersecting with genome editing technologies, potentially mitigating the inherent uncertainties associated with CRISPR systems. This integration aims to streamline experimental workflows and improve outcomes in gene therapy development, although empirical validation in diverse contexts remains ongoing. Consider the case of an undergraduate researcher with limited prior experience in…